Expression of Prostate-Specific Membrane Antigen in Tumor-Associated Neovasculature of Renal Neoplasms

Urology

Volumn 70, Issue 2, 2007, Pages 385-390

  Baccala, Angelo ^a   Sercia, Linda ^a   Li, Jianbo ^a   Heston, Warren ^a   Zhou, Ming ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; PROSTATE SPECIFIC MEMBRANE ANTIGEN;

ANGIOMYOLIPOMA; ANTIGEN EXPRESSION; ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY PROXIMAL TUBULE; KIDNEY TUMOR; ONCOCYTOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; SOLID TUMOR; TISSUE MICROARRAY; TRANSITIONAL CELL CARCINOMA; TUMOR VASCULARIZATION;

ANTIGENS, SURFACE; CARCINOMA, RENAL CELL; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; KIDNEY NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 34548462642     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.03.025     Document Type: Article

References (16)

1. Eble J.N., World Health Organization, and International Agency for Research on Cancer. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs (2004), IARC Press, Oxford University Press, Lyon, Oxford
2. Cohen D., and Zhou M. Molecular genetics of familial renal cell carcinoma syndromes. Clin Lab Med 25 (2005) 259-277
3. Wildberger J.E., Adam G., Boeckmann W., et al. Computed tomography characterization of renal cell tumors in correlation with histopathology. Invest Radiol 32 (1997) 596-601
4. Choueiri T.K., Bukowski R.M., and Rini B.I. The current role of angiogenesis inhibitors in the treatment of renal cell carcinoma. Semin Oncol 33 (2006) 596-606
5. Silver D.A., Pellicer I., Fair W.R., et al. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res 3 (1997) 81-85
6. Bander N.H. Technology insight: monoclonal antibody imaging of prostate cancer. Nat Clin Pract Urol 3 (2006) 216-225
7. Chang S.S., Reuter V.E., Heston W.D., et al. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res 59 (1999) 3192-3198
8. Lopes A.D., Davis W.L., Rosenstraus M.J., et al. Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5. Cancer Res 50 (1990) 6423-6429
9. Kinoshita Y., Kuratsukuri K., Landas S., et al. Expression of prostate-specific membrane antigen in normal and malignant human tissues. World J Surg 30 (2006) 628-636
10. Dumas F., Gala J.L., Berteau P., et al. Molecular expression of PSMA mRNA and protein in primary renal tumors. Int J Cancer 80 (1999) 799-803
11. Chang S.S., Reuter V.E., Heston W.D., et al. Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen. Urology 57 (2001) 801-805
12. de la Taille A., Cao Y., Sawczuk I.S., et al. Detection of prostate-specific membrane antigen expressing cells in blood obtained from renal cancer patients: a potential biomarker of vascular invasion. Cancer Detect Prev 24 (2000) 579-588
13. de la Taille A., Katz A., Cao Y., et al. Blood-based RT-PCR assays of MN/CA9 or PSMA: clinical application in renal cancer patients. Urology 56 (2000) 393-398
14. Chang S.S., O'Keefe D.S., Bacich D.J., et al. Prostate-specific membrane antigen is produced in tumor-associated neovasculature. Clin Cancer Res 5 (1999) 2674-2681
15. Grauer L.S., Lawler K.D., Marignac J.L., et al. Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM′ protein in the LNCaP prostatic carcinoma cell line. Cancer Res 58 (1998) 4787-4789
16. Horoszewicz J.S., Kawinski E., and Murphy G.P. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res 7 (1987) 927-935